Questioning the current framework, the bench asked why all medicines and medical devices covered under the Essential Commodities Act should not be subjected to a uniform 16 percent markup cap.
SC questions Centre over wide gap between drug price to retailer and MRPs; asks why 16% cap should not...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment